The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Seclaris DC 250 mg Intramammary Suspension for dry cows

250 mg/syringe Intramammary suspension

Ceva Santé AnimaleVPA10815/047/001

Main Information

Trade NameSeclaris DC 250 mg Intramammary Suspension for dry cows
Active SubstancesCefalonium (as cefalonium dihydrate?)
Strength250 mg/syringe
Dosage FormIntramammary suspension
Licence HolderCeva Santé Animale
Licence NumberVPA10815/047/001

Group Information

ATC CodeQJ51DB90 cefalonium
Therapeutic ClassAntibacterial


Licence Issued08/12/2017
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back